A COMPARISON OF BISHYDROXYCOUMARIN AND WARFARIN SODIUM IN TERMS OF COAGULATION FACTOR CHANGES AND BLEEDING COMPLICATIONS

被引:4
作者
FREMONT, RE
WIEDMAN, M
LUBELL, D
机构
关键词
D O I
10.1097/00000441-196309000-00002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:265 / &
相关论文
共 22 条
[1]   PROTHROMBIN - A CRITIQUE OF METHODS FOR ITS DETERMINATION AND THEIR CLINICAL SIGNIFICANCE [J].
ALEXANDER, B ;
DEVRIES, A ;
GOLDSTEIN, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1949, 240 (11) :403-413
[2]  
BJERKELUND CJ, 1957, ACTA MED SCANDI S330
[3]   CLINICAL EXPERIENCE WITH COUMARIN ANTICOAGULANTS WARFARIN AND WARFARIN SODIUM [J].
CLATANOFF, DV ;
TRIGGS, PO ;
MEYER, OO .
ARCHIVES OF INTERNAL MEDICINE, 1954, 94 (02) :213-220
[4]   CLINICAL OBSERVATIONS ON USE OF WARFARIN (COUMADIN) SODIUM, A NEW ANTICOAGULANT [J].
FREMONT, RE ;
JAGENDORF, B .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1957, 165 (11) :1381-1388
[5]  
HILDEN T, 1961, LANCET, V2, P327
[6]  
LINK KP, 1944, HARVEY LECT, P162
[7]  
MANCHESTER B, 1957, ANN INT MED, V47, P202
[8]  
MCMICHAEL J, 1960, Lancet, V2, P991
[9]  
OREILLY RA, 1962, CIRCULATION, V26, P769
[10]   CONTROL OF ANTICOAGULANT THERAPY - USE OF NEW TESTS [J].
OWREN, PA .
ARCHIVES OF INTERNAL MEDICINE, 1963, 111 (02) :248-&